Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,778.00
Bid: 1,778.00
Ask: 1,778.50
Change: 0.00 (0.00%)
Spread: 0.50 (0.028%)
Open: 1,780.00
High: 1,793.50
Low: 1,766.50
Prev. Close: 1,778.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 2-FTSE 100 reverses course to end lower on Imperial slump

Thu, 20th Feb 2020 09:32

* FTSE 100 down 0.3%, FTSE 250 up 0.1%

* Ex-dividend trading drags down main bourse

* Smith+Nephew, Moneysupermarket.com among notable gainers

* Virus cases in South Korea deter more rapid gains
(Recasts with market reversing course, updates share prices
throughout)

By Shashwat Awasthi and Muvija M

Feb 20 (Reuters) - London's FTSE 100 handed back earlier
gains to record losses on Thursday as a 7.3% fall in tobacco
giant Imperial Brands overshadowed a 10% leap in medical
products maker Smith+Nephew.

The blue-chip index slipped 0.3% as Imperial Brands
tumbled on ex-dividend trading, while most other sectors
also traded in the red with a surge in coronavirus infections in
South Korea stoking fears about a deepening health crisis.

Smith+Nephew hit an all-time high and helped limit
losses on the index after the medical products maker forecast
another year of revenue growth.

The FTSE 250 midcap index ended the day with a 0.1%
rise, led by a 19% surge in price comparison website
Moneysupermarket.com following upbeat outlook and a 7%
jump in engineering firm Spectris after 2019 results.

For the most part, the British indexes have drawn support
this week from stimulus measures from China, which cut its
benchmark lending rate to cushion the impact of the coronavirus
epidemic.

Both indexes are headed for a week of gains.

"Investors are making a number of significant assumptions
that governments and central banks will be able to mitigate the
effects of any disruption in the short and medium term," CMC
Markets analyst Michael Hewson said.

"Time will tell whether that is a safe assumption to make,
however in the absence of anywhere else to put one's money, the
line of least resistance for now appears to be to buy stocks."

Among other notable gainers on the main index were defence
firm BAE Systems and lender Lloyds with gains
of 3% and 1.4%, respectively, after their annual results.

However, the FTSE 100's losses were deepened by 1%-1.7%
falls in GlaxoSmithKline and Unilever, whose
stocks also traded without dividend entitlement.

Small-cap bathroom and kitchen products supplier Norcros
slid 11% after it warned annual profit would miss market
expectations and supply chain disruptions due to the coronavirus
outbreak would likely hit performance.
(Reporting by Shashwat Awasthi in Bengaluru; Editing by Shounak
Dasgupta, Saumyadeb Chakrabarty and Alison Williams)

More News
3 Jan 2024 17:10

Miners, personal goods stocks drag FTSE 100 to two-week low

Burberry slips on rating downgrade

*

Read more
3 Jan 2024 16:52

LONDON MARKET CLOSE: Stocks down ahead of US Fed minutes

(Alliance News) - Stock prices in London closed lower on Wednesday, as investors nervously look ahead to the latest US Federal Reserve meeting minutes.

Read more
3 Jan 2024 12:10

LONDON MARKET MIDDAY: Stocks down before Fed minutes and US PMI data

(Alliance News) - Stock prices in London were down at midday on Wednesday, in cautious trade ahead of key US data and central bank minutes in the afternoon.

Read more
3 Jan 2024 11:07

Jefferies upgrades GSK to 'buy', cuts AstraZeneca to 'hold'

(Sharecast News) - Jefferies has upgraded its rating on GlaxoSmithKline to 'buy' and cut AstraZeneca to 'hold' as part of its review of the European pharma sector.

Read more
3 Jan 2024 09:23

LONDON BROKER RATINGS: GSK raised to 'buy'; AstraZeneca cut to 'hold'

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
3 Jan 2024 08:58

LONDON MARKET OPEN: Stocks mixed pre-Fed minutes, amid Asia losses

(Alliance News) - Stock prices in London opened mixed on Wednesday, ahead of US Federal Reserve meeting minutes and manufacturing PMI data for the US in the evening and afternoon respectively.

Read more
3 Jan 2024 07:54

LONDON BRIEFING: Stocks to open flat pre-Fed minutes, jobs data

(Alliance News) - The FTSE 100 is expected to open flat on Wednesday, as London's flagship index celebrates its 40th anniversary, after mostly downbeat trading in Asia and a tech sell-off in New York.

Read more
29 Dec 2023 13:01

LONDON MARKET CLOSE: UK equities outclassed by other markets in 2023

(Alliance News) - Stock prices in London closed mixed on Friday, the final trading day of 2023, as the annual returns from UK equities were outshone by international markets.

Read more
20 Dec 2023 13:29

GSK buys rights to Hansoh Pharma antibody-drug conjugate

(Sharecast News) - GSK has agreed to buy the rights to an antibody-drug conjugate (ADC) - HS-20093 - from Chinese biopharmaceutical group Hansoh Pharma.

Read more
19 Dec 2023 15:36

German court quashes CureVac patent after challenge by BioNTech

CureVac shares drop 40%Dispute over intellectual property with BioNTech to continue

*

Read more
18 Dec 2023 17:21

Energy stocks lift UK's FTSE 100, Vodafone shines

Vodafone jumps as Iliad offers to merge Italian units

*

Read more
18 Dec 2023 10:07

GSK's dostarlimab trial in endometrial cancer meets primary endpoint

(Alliance News) - GSK PLC on Monday said a trial of dostarlimab in combination with niraparib for treating endometrial cancer has met its primary endpoint.

Read more
18 Dec 2023 07:55

LONDON BRIEFING: Games Workshop seals Amazon deal for Warhammer 40,000

(Alliance News) - Stocks in London were set to retreat slightly on Monday, in line with equity markets in Asia, at the start of the last week before the Christmas holidays.

Read more
18 Dec 2023 07:18

GSK sees success in Jemperli endometrial cancer trial

(Sharecast News) - GSK released positive headline results from the planned analysis of its trial of Jemperli in endometrial cancer on Monday.

Read more
17 Dec 2023 15:16

PRESS: GSK looks for deals in China as rebuilds relationship

(Alliance News) - The Financial Times on Sunday reported that GSK PLC is looking for some new deals in China.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.